Commitments and contingencies (Details Narrative) - USD ($) |
3 Months Ended | 9 Months Ended | 12 Months Ended | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
Jul. 11, 2023 |
Aug. 27, 2021 |
Sep. 30, 2023 |
Jun. 30, 2020 |
Sep. 30, 2023 |
Dec. 31, 2022 |
Dec. 31, 2021 |
Oct. 31, 2022 |
Sep. 30, 2022 |
Aug. 31, 2022 |
|
| Law suit filing date | May 28, 2019 | |||||||||
| G Farma Settlors [Member] | ||||||||||
| Litigation settlement amount awarded from other party | $ 2,539,597 | $ 2,539,597 | $ 2,539,597 | |||||||
| Litigation settlement default amount | 2,494,450 | |||||||||
| Interest receivable | 40,219 | $ 56,358 | 56,358 | |||||||
| Litigation settlement costs | 1,643 | |||||||||
| Attorneys fee | $ 3,285 | |||||||||
| Debt instrument, interest rate, effective percentage | 10.00% | |||||||||
| Other income | $ 0 | $ 3,550 | $ 2,000 | |||||||
| Settlement Agreement and Mutual Release [Member] | G Farma Settlors [Member] | ||||||||||
| Liability for Unpaid Claims and Claims Adjustment Expense Schedule, Discussion | The Settlement Agreement requires the G Farma Settlors to pay the Company an aggregate of $500,000 plus interest, payable monthly as follows: (i) $500 per month for 12 months beginning on September 5, 2021, (ii) $1,000 per month for 12 months beginning September 5, 2022, (iii) $2,000 per month for 12 months beginning September 5, 2023, and (iv) increasing by an additional $1,000 per month on each succeeding September 5th thereafter, until the settlement amount and accrued unpaid interest is paid in full. Interest on the unpaid balance shall initially accrue at the rate of 4.25%, commencing February 25, 2021, and shall be adjusted on February 25th of each year to equal the Prime Rate as published in the Wall Street Journal plus 1% | |||||||||
| Liability for unpaid claims and claims adjustment expense, net | $ 500,000 | $ 500,000 | $ 500,000 | $ 500,000 | ||||||
| Liability for unpaid claims | $ 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | ||||||
| Liability for accrued unpaid interest | $ 2,000,000 | $ 2,000,000 | $ 2,000,000 | |||||||
| G FarmaLabs Limited [Member] | ||||||||||
| Sale leaseback transaction, net book value | $ 622,670 | |||||||||
| Loss contingency receivable, proceeds | $ 249,481 | |||||||||
| X | ||||||||||
- Definition Liability for accrued unpaid interest. No definition available.
|
| X | ||||||||||
- Definition Litigation settlement default amount. No definition available.
|
| X | ||||||||||
- Definition Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Liability as of the balance sheet date for amounts representing estimated cost of settling unpaid claims under the terms of the underlying insurance policies, less estimated reinsurance recoveries on such claims. This includes an estimate for claims which have been incurred but not reported. Claim adjustment expenses represent the costs estimated to be incurred in the settlement of unpaid claims. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Sum of adjustments to the estimated reserve for unpaid claims and claims adjustment expense. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Discussion accompanying a schedule reflecting the financial activity during the period in the reserves for unpaid claims and claims adjustment expense. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount awarded from other party in judgment or settlement of litigation. No definition available.
|
| X | ||||||||||
- Definition Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees. No definition available.
|
| X | ||||||||||
- Definition Interest expense (income) directly attributable to an award in settlement of litigation. No definition available.
|
| X | ||||||||||
- Definition States the date the complaint was formally filed in a court of law, in arbitration or mediation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of cash inflow from the collection of receivables related to a loss contingency. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of revenue and income classified as other. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The net book value of the asset(s) sold in connection with the sale of the property to another party and lease back to the seller. Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|